[1] |
KANG Yi-xing, SU Yan-ze, ZHANG Chao-chuang, LEI De-feng, LIN Zhi-heng, WANG Rong-rui, CHEN Xiao, LIU Ji-kui.
The effect of collagen type Ⅰ in the progression of pancreatic cancer
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 277-282.
|
[2] |
DENG Jing, CHEN Huan-wei.
Comparative study on the safety and efficacy of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(02): 120-125.
|
[3] |
HE Chong, ZHOU Shu-rui, LI Ya-qing, CHEN Shao-jie, LIAN Guo-da, CHEN Shang-xiang, HUANG Kai-hong.
Screening of ferroptosis-related genes and construction of prognostic prediction model in pancreatic cancer
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(01): 14-23.
|
[4] |
LIN Xing-yi, TIAN Zhen-feng, PAN Le-le, SU Ming-xin, CHEN Yin-ting.
Metabolic pathways and key gene analysis of circulating tumor cells in pancreatic cancer based on GEO database
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(01): 34-41.
|
[5] |
LOU Wen-hui.
Whole disease journey management in the diagnosis and treatment of pancreatic cancer
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 1-5.
|
[6] |
HAN Shi-ji, LIAN Guo-da, CHEN Shao-jie, HUANG Kai-hong, LI Jia-jia.
Construction and functional verification of immortalized human pancreatic stellate cells
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 36-43.
|
[7] |
YUAN Guan-ping, JIANG Zhi-min, MA Dong, PAN Zi-chun, DING Ying, XIE De-rong.
FOLFIRINOX regimen versus AG regimen as first-line therapy in advanced pancreatic cancer: A multicenter observational study
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 53-58.
|
[8] |
HUANG Xian-xian, LI Yuan-hua, HUANG Feng-ting, ZHANG Shi-neng, ZHUANG Yan-yan..
Effect on biological function after XPO1 knockout in pancreatic cancer cell line via CRISPR/Cas9
[J]. Lingnan Modern Clinics in Surgery, 2020, 20(03): 280-284.
|
[9] |
LI Xuan-na, CHEN Shang-xiang, LIAN Guo-da, CHEN Shao-jie, HUANG Kai-hong.
Analysis of clinicopathological features of 240 cases of pancreatic cancer with liver metastasis and prognostic risk factors
[J]. Lingnan Modern Clinics in Surgery, 2020, 20(02): 151-154.
|
[10] |
REN Xiaofan1, LI zhihua1.
Expression and clinical significance of exosomal long non?coding RNA CCAT1 in pancreatic cancer
[J]. Lingnan Modern Clinics in Surgery, 2019, 19(01): 23-27.
|
[11] |
ZHANG Guangtao1, LIANG Yue2, LI Minghua3.
Construction and verification of plasmid mediated LAPTM4B over expressing pancreatic cancer cell line PANC?1
[J]. Lingnan Modern Clinics in Surgery, 2019, 19(01): 44-47.
|
[12] |
WEI Lusheng, LU Yuanting, YE Huilin, ZHOU Quanbo, CHEN Rufu.
Expression and clinical significance of SATB-1 and α-SMA in pancreatic cancer
[J]. Lingnan Modern Clinics in Surgery, 2018, 18(02): 195-200.
|
[13] |
Guo Yubo, Zeng Linjuan, Su Hong, Huang Kaihong.
Research advances in the peripheral nerve metastasis of malignant tumors
[J]. Lingnan Modern Clinics in Surgery, 2014, 14(02): 211-213.
|
[14] |
.
Understanding of the guideline of diagnosis and treatment f pancreatic carcinoma in 2012 ASCO congress
[J]. Lingnan Modern Clinics in Surgery, 2013, 13(01): 4-6.
|
[15] |
Liao Kai, Bi Zhuofei, He Yan, Liu Yimin.
Experimental study on chitosan as a gene delivery carrier combined with MUC1 gene vaccine for the treatment of pancreatic cancer
[J]. Lingnan Modern Clinics in Surgery, 2013, 13(01): 38-40.
|